Latest AI and machine learning research in primary care for healthcare professionals.
Type 1 diabetes (T1D) is associated with microbial dysbiosis. While most research has focused on the...
While extensive efforts have characterized lymphoid populations that contribute to pancreatic ‘insul...
Multiple studies have highlighted the human microbiome’s potential as a biomarker for diagnosing dis...
The nasopharyngeal microbiome acts as a dynamic interface between the human body and environmental e...
RNA-based therapies are a rapidly expanding field, offering treatments for a wide range of diseases,...
Type 1 diabetes mellitus (T1DM) is the most common severe chronic disease in children and adolescent...
HyperLab, developed by HITS, is a web-based, AI-driven drug discovery platform designed to increase ...
In type 2 diabetes (T2D), molecular pathways driving β cell failure are difficult to resolve with st...
Polygenic Risk Scores (PRS) are emerging tools for predicting an individual’s genetic risk for compl...
Metabolic dysfunction-associated steatotic liver disease (MASLD, previously NAFLD) is a frequent co-...
In hematology/oncology clinics, molecular diagnostics based on nucleic acid sequencing or hybridizat...
Muscle atrophy poses a serious threat to human health, with its primary pathogenic mechanisms closel...
Inflammation is central to pulmonary arterial hypertension (PAH) pathogenesis. The liver regulates s...
Histologically stained tissue sections are considered the gold standard for studying microscopic ana...
Lead optimization plays an important role in preclinical drug discovery. While deep learning has acc...
This paper introduces an innovative Electronic Health Record (EHR) foundation model that integrates ...
Primary and metastatic brain tumors are among the deadliest and treatment-resistant cancers, mainly ...
Enzyme engineering is central to developing biocatalysts with improved activity and specificity, yet...
Continuous glucose monitoring (CGM) systems play a crucial role in diabetes care. Yet, they focus so...
Esophageal squamous cell carcinoma (ESCC) is a disease with limited tools for early screening and a ...
Antibody discovery remains constrained by resource-intensive experimental screening approaches that ...